Literature DB >> 31167133

Alternative Translation Initiation Generates a Functionally Distinct Isoform of the Stress-Activated Protein Kinase MK2.

Philipp Trulley1, Goda Snieckute2, Dorte Bekker-Jensen3, Manoj B Menon1, Robert Freund1, Alexey Kotlyarov1, Jesper V Olsen3, Manuel D Diaz-Muñoz4, Martin Turner5, Simon Bekker-Jensen6, Matthias Gaestel7, Christopher Tiedje8.   

Abstract

Alternative translation is an important mechanism of post-transcriptional gene regulation leading to the expression of different protein isoforms originating from the same mRNA. Here, we describe an abundant long isoform of the stress/p38MAPK-activated protein kinase MK2. This isoform is constitutively translated from an alternative CUG translation initiation start site located in the 5' UTR of its mRNA. The RNA helicase eIF4A1 is needed to ensure translation of the long and the known short isoforms of MK2, of which the molecular properties were determined. Only the short isoform phosphorylated Hsp27 in vivo, supported migration and stress-induced immediate early gene (IEG) expression. Interaction profiling revealed short-isoform-specific binding partners that were associated with migration. In contrast, the long isoform contains at least one additional phosphorylatable serine in its unique N terminus. In sum, our data reveal a longer isoform of MK2 with distinct physiological properties.
Copyright © 2019 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  5′ UTR; MAPKAPK2; alternative translation initiation; eIF4A1; ribosome footprinting

Mesh:

Substances:

Year:  2019        PMID: 31167133     DOI: 10.1016/j.celrep.2019.05.024

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  7 in total

1.  Mitogen-activated protein kinase-activated protein kinase-2 (MK2) and its role in cell survival, inflammatory signaling, and migration in promoting cancer.

Authors:  Deri Morgan; Kiersten L Berggren; Colby D Spiess; Hannah M Smith; Ajay Tejwani; Scott J Weir; Christopher E Lominska; Sufi M Thomas; Gregory N Gan
Journal:  Mol Carcinog       Date:  2021-09-24       Impact factor: 4.784

Review 2.  The plasticity of mRNA translation during cancer progression and therapy resistance.

Authors:  Lucilla Fabbri; Alina Chakraborty; Caroline Robert; Stéphan Vagner
Journal:  Nat Rev Cancer       Date:  2021-08-02       Impact factor: 60.716

3.  mCherry contains a fluorescent protein isoform that interferes with its reporter function.

Authors:  Maxime Fages-Lartaud; Lisa Tietze; Florence Elie; Rahmi Lale; Martin Frank Hohmann-Marriott
Journal:  Front Bioeng Biotechnol       Date:  2022-08-09

4.  The Bombyx mori Nucleopolyhedrovirus GP64 Retains the Transmembrane Helix of Signal Peptide to Contribute to Secretion across the Cytomembrane.

Authors:  Bifang Hao; Lin Liu; Na Liu; Luping Sun; Fengxiu Fan; Jinshan Huang
Journal:  Microbiol Spectr       Date:  2022-08-08

5.  MK2 degradation as a sensor of signal intensity that controls stress-induced cell fate.

Authors:  Nuria Gutierrez-Prat; Monica Cubillos-Rojas; Begoña Cánovas; Antonija Kuzmanic; Jalaj Gupta; Ana Igea; Elisabet Llonch; Matthias Gaestel; Angel R Nebreda
Journal:  Proc Natl Acad Sci U S A       Date:  2021-07-20       Impact factor: 11.205

6.  Enhancing chemotherapy response through augmented synthetic lethality by co-targeting nucleotide excision repair and cell-cycle checkpoints.

Authors:  Yi Wen Kong; Erik C Dreaden; Sandra Morandell; Wen Zhou; Sanjeev S Dhara; Ganapathy Sriram; Fred C Lam; Jesse C Patterson; Mohiuddin Quadir; Anh Dinh; Kevin E Shopsowitz; Shohreh Varmeh; Ömer H Yilmaz; Stephen J Lippard; H Christian Reinhardt; Michael T Hemann; Paula T Hammond; Michael B Yaffe
Journal:  Nat Commun       Date:  2020-08-17       Impact factor: 14.919

7.  Rapamycin, Acarbose and 17α-estradiol share common mechanisms regulating the MAPK pathways involved in intracellular signaling and inflammation.

Authors:  Lily Wink; Richard A Miller; Gonzalo G Garcia
Journal:  Immun Ageing       Date:  2022-02-01       Impact factor: 6.400

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.